Plan B hotline
This article was originally published in The Tan Sheet
Executive Summary
A toll-free hotline will make the "morning-after" pill readily available to Wisconsin women despite FDA's rejection of OTC status for the product. "We're pretty much ignoring them and pushing ahead," said Patricia Bonhart, president of the Wisconsin Family Planning & Reproductive Health Association (WFPRHA). The organization will use monetary contributions to run advertising for the 800 number, including information on use and availability of emergency contraception. WFPRHA will mail the pill to women overnight if necessary...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.